Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Heppe Medical Chitosan (HMC) is a specialized German biotechnology company focused on the production and development of high-purity chitin, chitosan, and their derivatives for the pharmaceutical and medical device industries. Founded in 2005, the company provides a comprehensive portfolio of over 100 different products, ranging from standard grades to ultrapure, GMP-compliant chitosan used as functional excipients and active ingredients. HMC supports its partners through the entire product lifecycle, offering contract manufacturing and customized development services for advanced applications such as drug delivery systems, regenerative medicine, and specialized wound care. The company is ISO 13485 certified, ensuring the high quality and consistency required for regulated medical and pharmaceutical markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heppe Medical Chitosan.